Already the world’s second-largest exporter of Professional and Business Services, the UK government is doubling down on what ...
The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...
Elizabeth O'Mahony, Interim Director General, Finance / Chief Financial Officer Paper type: For discussion 5 February 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results